Cooper, Jessica A. http://orcid.org/0000-0002-5373-1945
Nuutinen, Makiah R.
Lawlor, Victoria M.
DeVries, Brittany A. M.
Barrick, Elyssa M.
Hossein, Shabnam
Cole, Daniel J.
Leonard, Chelsea V.
Hahn, Emma C.
Teer, Andrew P.
Shields, Grant S.
Slavich, George M. http://orcid.org/0000-0001-5710-3818
Ongur, Dost
Jensen, J. Eric
Du, Fei http://orcid.org/0000-0002-9549-4255
Pizzagalli, Diego A. http://orcid.org/0000-0002-7772-1143
Treadway, Michael T. http://orcid.org/0000-0002-5913-114X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (F32 MH115692, K24 MH104449, K24 MH104449, R37 MH068376, R01 MH101521, R00MH102355, R01MH108605)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 18 May 2020
Accepted: 19 April 2021
First Online: 26 May 2021
Competing interests
: M.T.T. discloses that he has received consulting fees in the last three years from Avanir Pharmaceuticals and BlackThorn Therapeutics. M.T.T. declares no other competing interests, financial or otherwise. D.A.P. discloses that he has received consulting fees in the last 3 years from BlackThorn Therapeutics, Boehreinger Ingelheim, Compass Pathway, Engrail Pharmaceuticals, Otsuka Pharmaceuticals, and Takeda Pharmaceuticals; one honorarium from Alkermes; stock options from BlackThorn Therapeutics; and funding from NIMH, Brain and Behavior Research Foundation, the Dana Foundation, and Millennium Pharmaceuticals. D.A.P. declares no other competing interests, financial or otherwise. All other authors declare no competing interests.